STERIS plc (STE) News
Follow STERIS plc (STE) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 30 public stories across 14 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Steris Prices $1.5 Billion Senior Notes Offering
The offering comprises $750 million due 2033 and $750 million due 2036.
EQUITY | Nov 12, 2026, 09:53 PM UTC
M
STERIS Prices $1.5 Billion in Senior Notes to Fund Pending Acquisition
STERIS priced $1.5 billion in senior notes, with proceeds intended in part to fund its pending acquisition of Xodus Medical.
MNA | Nov 12, 2026, 09:19 PM UTC
M
STERIS Reports Revenue of $1.59B and EPS of $2.19 for 3Q 2026
STERIS said fiscal second-quarter 2027 revenue and earnings increased year over year, with operating income also rising.
EARNINGS | Nov 05, 2026, 09:19 PM UTC
M
Steris Secures $1.6 Billion Revolving Credit Facility
Steris entered into a $1.6 billion revolving credit facility.
EQUITY | Nov 04, 2026, 11:23 PM UTC
M
STERIS Q2 Profit Rises to $213.7 Million
STERIS reported net income of $213.7 million, or $2.19 per share, compared with $191.9 million, or $1.94 per share, a year earlier.
EQUITY | Nov 04, 2026, 11:22 PM UTC
M
Steris shares rise 6.5% after second-quarter results beat
Steris shares rose 6.5% to $264 after its second-quarter results beat.
EARNINGS | Nov 04, 2026, 10:39 PM UTC
M
STERIS Enters $1.60 Billion Revolving Credit Facility
EQUITY | Nov 04, 2026, 10:16 PM UTC
M
Steris Beats Q2 EPS by $0.26, Guides FY27 Above Consensus
Steris reported Q2 earnings of $2.94 per share, excluding non-recurring items, $0.26 above consensus, and guided FY27 EPS above consensus.
EARNINGS | Nov 04, 2026, 10:07 PM UTC
M
Steris Q2 Adjusted EPS Beats; Fiscal 2027 Outlook Lifted
EARNINGS | Nov 04, 2026, 09:41 PM UTC
M
STERIS Reports Fiscal Q2 2027 Results; Revenue Rises 9%
STERIS said fiscal second-quarter revenue increased 9%, with constant-currency organic revenue growth of 8%.
EQUITY | Nov 04, 2026, 09:32 PM UTC
M
Steris Announces Dividend of R$ 0.1335682430 per Unit
Steris announced a fourth-quarter 2026 dividend of R$ 0.1335682430 per unit.
EQUITY | Oct 29, 2026, 07:52 PM UTC
M
STERIS Keeps Quarterly Dividend at $0.69 a Share
STERIS kept its quarterly dividend at $0.69 per share. It is payable Dec. 17 to shareholders of record Nov. 17.
EQUITY | Oct 28, 2026, 09:46 PM UTC
M
STERIS Announces Quarterly Dividend of $0.69 Per Share
STERIS said the dividend is payable December 17, 2026, to shareholders of record at the close of business on November 1.
EQUITY | Oct 28, 2026, 08:34 PM UTC
M
Steris to Acquire Xodus Medical for $2.1 Billion in Cash
Steris announced a definitive agreement to acquire Xodus Medical for $2.1 billion in cash, with up to $150 million in additional earnout tied to 2028 performance. The deal is expected to close by Dec. 31, 2026, subject t
EQUITY | Oct 13, 2026, 08:34 PM UTC
L
Xodus Medical agrees to be acquired by STERIS
MNA | Oct 12, 2026, 06:44 PM UTC
M
Steris Agrees to Acquire Xodus Medical for $2.1 Billion
Steris signed an agreement to acquire specialty-surgical-products business Xodus Medical. Steris said the deal would expand its portfolio with consumable products used in surgeries.
EQUITY | Oct 12, 2026, 12:47 PM UTC
M
Steris to Buy Xodus Medical for $2.1 Billion
Steris said it will buy privately held surgical products maker Xodus Medical for $2.1 billion.
MNA | Oct 12, 2026, 12:08 PM UTC
M
STERIS to acquire Xodus Medical
STERIS signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business focused on patient and OR staff safety.
EQUITY | Oct 12, 2026, 12:01 PM UTC
L
STERIS to present at Morgan Stanley Healthcare Conference Sept. 15
STERIS plc says it will participate in the Morgan Stanley Healthcare Conference in New York City on Tuesday, September 15, 2026. Dan Carestio, President and CEO, is scheduled to present at 1:05 p…
EQUITY | Sep 01, 2026, 08:37 PM UTC
L
STE - STERIS to Present at the Morgan Stanley Healthcare Conference
STE - STERIS to Present at the Morgan Stanley Healthcare Conference
EQUITY | Sep 01, 2026, 08:30 PM UTC
L
Near 200dma support LIN KKR OGE MCK STE APG MLI WRB FHB GMED SRPT UTHR GNRC GNTX CMI RITM WTM RMD WFRD
Near 200dma support LIN KKR OGE MCK STE APG MLI WRB FHB GMED SRPT UTHR GNRC GNTX CMI RITM WTM RMD WFRD
EQUITY | Aug 20, 2026, 07:27 PM UTC
H
Steris Widens FY2027 Adj EPS Guidance from $11.10-$11.30 to $11.00-$11.30 vs $11.16 Est; Affirms FY2027 Sales Guidance of $6.352B-$6.411B vs
Steris (NYSE: STE ) widens FY2027 Adj EPS guidance from $11.10-$11.30 to $11.00-$11.30 vs $11.16 analyst estimate. Affirms FY2027 sales outlook from $6.352 billion-$6.411 billion to $6.352 billion-$6.411 billion vs $6.37
EARNINGS | Aug 05, 2026, 08:32 PM UTC
H
STE - STERIS Announces Financial Results for Fiscal 2027 First Quarter
STE - STERIS Announces Financial Results for Fiscal 2027 First Quarter
EARNINGS | Aug 05, 2026, 08:30 PM UTC
M
STERIS Invests $600 Million In North Carolina Facility
STERIS invests in new manufacturing center
EQUITY | Aug 05, 2026, 12:45 PM UTC
M
STERIS Raises Dividend
STERIS increases dividend to $0.69 per share
EQUITY | Jul 30, 2026, 08:30 PM UTC
L
STE new Buy W/ $275 PT @ UBS
STE new Buy W/ $275 PT @ UBS
EQUITY | Jul 28, 2026, 12:44 PM UTC
L
STE Initiated Buy W/$275.00 PT at UBS
STE Initiated Buy W/$275.00 PT at UBS
EQUITY | Jul 28, 2026, 11:49 AM UTC
L
Top Initiations: ATEC BDX BLCO EW SGHT SIBN STE ZBH: BUY @ UBS COO GKOS GMED IART RXST TFX TMDX: NEUTRAL @ UBS INSP STAA: SELL @ UBS BNTC: O
Top Initiations: ATEC BDX BLCO EW SGHT SIBN STE ZBH: BUY @ UBS COO GKOS GMED IART RXST TFX TMDX: NEUTRAL @ UBS INSP STAA: SELL @ UBS BNTC: OUTPERFORM @ Wedbush CRWD: BUY @ Loop FTH: OUTPERFORM @ Opp HRB: EQUAL WEIGHT @ S
EQUITY | Jul 28, 2026, 11:11 AM UTC
L
STE - STERIS to Host a Conference Call for Fiscal 2027 First Quarter on August 6, 2026
STE - STERIS to Host a Conference Call for Fiscal 2027 First Quarter on August 6, 2026
EQUITY | Jul 27, 2026, 08:30 PM UTC
L
TOUR EIFFEL: STE - Bilan Semestriel S1 2026 du contrat de liquidité géré par la Société de Bourse Gilbert Dupont puis par Invest Securities
SOCIETE DE LA TOUR EIFFEL Société anonyme au capital de 664 452 560 euros Siège social: 11/13 avenue de Friedland - 75008 PARIS
EQUITY | Jul 03, 2026, 04:08 PM UTC